Osteopontin for the prediction and treatment of cardiovascular diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 4, 2012
Issued Date -
N/A
app pub date -
Mar 3, 2008
filing date -
Mar 2, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully